本文選題：MSCT + 肝癌�。� 參考：《臨床放射學(xué)雜志》2017年06期

【摘要】：目的探討MSCT肝包膜侵犯征象對(duì)肝癌微血管侵犯(MVI)的診斷價(jià)值。方法回顧性分析初診經(jīng)手術(shù)病理證實(shí)的單發(fā)肝癌132例,所有病例術(shù)前均行MSCT平掃及多期增強(qiáng)掃描。將MSCT肝包膜侵犯征象與手術(shù)病理結(jié)果進(jìn)行對(duì)照分析。結(jié)果 MSCT肝包膜侵犯征象與病理肝包膜侵犯、肝癌MVI之間存在顯著關(guān)聯(lián)(P0.01);MSCT肝包膜侵犯征象診斷肝癌MVI的敏感度、特異度、準(zhǔn)確率分別為83.3%(40/48)、67.9%(57/84)、73.5%(97/132)。結(jié)論 MSCT肝包膜侵犯征象可以作為評(píng)估肝癌MVI的一種依據(jù)。
[Abstract]:Objective to evaluate the diagnostic value of MSCT hepatic capsule invasion in hepatocellular carcinoma (HCC) with microvessel invasion. Methods A retrospective analysis was made on 132 cases of primary hepatic carcinoma confirmed by surgery and pathology. All cases were performed MSCT plain scan and multiphase enhanced scan before operation. The MSCT hepatic capsule invasion signs were compared with the results of operation and pathology. Results there was a significant correlation between MSCT hepatic capsule invasion and pathological hepatic capsule invasion. The sensitivity, specificity and accuracy of hepatic envelope invasion in diagnosis of liver cancer MVI were 83.340 / 48 / 67.9g / 73.5 / 97 / 132respectively. Conclusion MSCT hepatic capsule invasion can be used as a basis for evaluating liver cancer MVI.
【作者單位】： 廣西醫(yī)科大學(xué)附屬腫瘤醫(yī)院放射科;
【基金】：廣西科學(xué)研究與技術(shù)開發(fā)計(jì)劃項(xiàng)目(編號(hào):桂科攻1355005-3-1) 廣西衛(wèi)生和計(jì)劃生育委員會(huì)自籌經(jīng)費(fèi)科研項(xiàng)目(編號(hào):Z2016476) 2017年廣西研究生教育創(chuàng)新計(jì)劃項(xiàng)目資助(編號(hào):YCBZ2017042)
【分類號(hào)】：R730.44;R735.7
，

本文編號(hào)：1947506